Form 4: Teladoc Health Executive Adam C. Vandervoort Reports Stock Transactions
SEC Form 4 Filing
Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, reports the acquisition and disposal of common stock and derivative securities.
Summary
- Adam C. Vandervoort, the Chief Legal Officer and Secretary of Teladoc Health, filed a Form 4 detailing changes in beneficial ownership.
- On May 31, 2024, Vandervoort acquired 1,505 shares of common stock through the conversion of performance stock units.
- Additionally, on the same day, he acquired 1,881 and 4,417 shares of common stock through the conversion of restricted stock units.
- On June 3, 2024, Vandervoort disposed of 4,015 shares of common stock at a price of $11.157 per share.
- Following these transactions, Vandervoort beneficially owns 41,264 shares of Teladoc Health common stock.
- He also holds 10,540 performance stock units, 5,643 restricted stock units from a 2022 grant, and 30,925 restricted stock units from a 2023 grant.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency to investors regarding insider activity.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive stock transactions.
Key Dates
| Date | Description |
|---|---|
| 03/01/2022 | Reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/03/2023 | Reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/01/2024 | The reporting person earned 18,067 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 05/31/2024 | Conversion of 1,505 performance stock units to common stock. |
| 05/31/2024 | Conversion of 1,881 restricted stock units to common stock. |
| 05/31/2024 | Conversion of 4,417 restricted stock units to common stock. |
| 06/03/2024 | Sale of 4,015 shares of common stock at $11.157 per share. |
| 06/04/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.